The CTRI is partially funded by a Clinical and Translational Science Award (CTSA) from the National Institutes of Health. The mission of the CTSA program is to accelerate discoveries toward better health. The CTSA is a highly competitive, 5-year grant that helps awardees translate research discoveries into commercially available drugs and devices for prevention, diagnosis, or treatment of human diseases and disorders. As the CTSA-funded institutes carry out this mission, we can expect to see an increase in research efficiency, an enhancement in the education of our trainees, and the breaking down of barriers, such as red tape and silo culture, that delay the progress of candidates to market.
For more information, please visit here.